LOUISE CONVERY: Open Payments
NPI 1699728287 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 28 payments from 11 companies in 2025. Trend: 2023 $1,025 · 2024 $953 · 2025 $604
Food & beverage: $593Education: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| PFIZER INC. | 5 | $118 |
| ABBVIE INC. | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $20 |
| Medtronic, Inc. | 1 | $16 |
Products named: ELIQUIS, FARXIGA, JARDIANCE, UBRELVY, MOUNJARO, VRAYLAR, Kerendia, RECORLEV.
Industry payments across IA — which companies pay providers there.
